Biblio

Export 1564 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Y. Yin, Zhao, Y., Han, S., Zhang, N., Chen, H., and Wang, X., “Autophagy-ERK1/2-Involved Disinhibition of Hippocampal Neurons Contributes to the Pre-Synaptic Toxicity Induced by Aβ42 Exposure.”, J Alzheimers Dis, vol. 59, no. 3, pp. 851-869, 2017.
S. Eketjäll, Janson, J., Kaspersson, K., Bogstedt, A., Jeppsson, F., Fälting, J., Haeberlein, S. Budd, Kugler, A. R., Alexander, R. C., and Cebers, G., “AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1109-23, 2016.
G. Cebers, Alexander, R. C., Haeberlein, S. Budd, Han, D., Goldwater, R., Ereshefsky, L., Olsson, T., Ye, N., Rosen, L., Russell, M., Maltby, J., Eketjäll, S., and Kugler, A. R., “AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1039-1053, 2017.
B
K. Håkansson, Ledreux, A., Daffner, K., Terjestam, Y., Bergman, P., Carlsson, R., Kivipelto, M., Winblad, B., Granholm, A. - C., and Mohammed, A. Kadir H., “BDNF Responses in Healthy Older Persons to 35 Minutes of Physical Exercise, Cognitive Training, and Mindfulness: Associations with Working Memory Function.”, J Alzheimers Dis, vol. 55, no. 2, pp. 645-657, 2017.
N. Cortés, Andrade, V., and Maccioni, R. B., “Behavioral and Neuropsychiatric Disorders in Alzheimer's Disease.”, J Alzheimers Dis, 2018.
A. D. Dekker, Sacco, S., Carfi, A., Benejam, B., Vermeiren, Y., Beugelsdijk, G., Schippers, M., Hassefras, L., Eleveld, J., Grefelman, S., Fopma, R., Bomer-Veenboer, M., Boti, M., G Oosterling, D. E., Scholten, E., Tollenaere, M., Checkley, L., Strydom, A., Van Goethem, G., Onder, G., Blesa, R., Eulenburg, C. Zu, Coppus, A. M. W., Rebillat, A. - S., Fortea, J., and De Deyn, P. P., “The Behavioral and Psychological Symptoms of Dementia in Down Syndrome (BPSD-DS) Scale: Comprehensive Assessment of Psychopathology in Down Syndrome.”, J Alzheimers Dis, vol. 63, no. 2, pp. 797-819, 2018.
A. D. Dekker, Sacco, S., Carfi, A., Benejam, B., Vermeiren, Y., Beugelsdijk, G., Schippers, M., Hassefras, L., Eleveld, J., Grefelman, S., Fopma, R., Bomer-Veenboer, M., Boti, M., G Oosterling, D. E., Scholten, E., Tollenaere, M., Checkley, L., Strydom, A., Van Goethem, G., Onder, G., Blesa, R., Eulenburg, C. Zu, Coppus, A. M. W., Rebillat, A. - S., Fortea, J., and De Deyn, P. P., “The Behavioral and Psychological Symptoms of Dementia in Down Syndrome (BPSD-DS) Scale: Comprehensive Assessment of Psychopathology in Down Syndrome.”, J Alzheimers Dis, vol. 63, no. 2, pp. 797-819, 2018.
A. D. Dekker, Sacco, S., Carfi, A., Benejam, B., Vermeiren, Y., Beugelsdijk, G., Schippers, M., Hassefras, L., Eleveld, J., Grefelman, S., Fopma, R., Bomer-Veenboer, M., Boti, M., G Oosterling, D. E., Scholten, E., Tollenaere, M., Checkley, L., Strydom, A., Van Goethem, G., Onder, G., Blesa, R., Eulenburg, C. Zu, Coppus, A. M. W., Rebillat, A. - S., Fortea, J., and De Deyn, P. P., “The Behavioral and Psychological Symptoms of Dementia in Down Syndrome (BPSD-DS) Scale: Comprehensive Assessment of Psychopathology in Down Syndrome.”, J Alzheimers Dis, vol. 63, no. 2, pp. 797-819, 2018.
A. D. Dekker, Ulgiati, A. M., Groen, H., Boxelaar, V. A., Sacco, S., Falquero, S., Carfi, A., di Paola, A., Benejam, B., Valldeneu, S., Fopma, R., Oosterik, M., Hermelink, M., Beugelsdijk, G., Schippers, M., Henstra, H., Scholten-Kuiper, M., Willink-Vos, J., de Ruiter, L., Willems, L., de Jong, A. Loonstra-, Coppus, A. M. W., Tollenaere, M., Fortea, J., Onder, G., Rebillat, A. - S., Van Dam, D., and De Deyn, P. P., “The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1505-1527, 2021.
A. D. Dekker, Ulgiati, A. M., Groen, H., Boxelaar, V. A., Sacco, S., Falquero, S., Carfi, A., di Paola, A., Benejam, B., Valldeneu, S., Fopma, R., Oosterik, M., Hermelink, M., Beugelsdijk, G., Schippers, M., Henstra, H., Scholten-Kuiper, M., Willink-Vos, J., de Ruiter, L., Willems, L., de Jong, A. Loonstra-, Coppus, A. M. W., Tollenaere, M., Fortea, J., Onder, G., Rebillat, A. - S., Van Dam, D., and De Deyn, P. P., “The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1505-1527, 2021.
M. Ibarria, Alegret, M., Valero, S., Morera, A., Guitart, M., Cañabate, P., Moreno, M., Lara, S., Diego, S., Hernández, J., Tantinyá, N., Vera, M., Hernandez, I., Becker, J. T., Ruiz, A., Boada, M., and Tárraga, L., “Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 2, pp. 559-66, 2016.
I. Chalatsa, Arvanitis, D. A., Mikropoulou, E. V., Giagini, A., Papadopoulou-Daifoti, Z., Aligiannis, N., Halabalaki, M., Tsarbopoulos, A., Skaltsounis, L. A., and Sanoudou, D., “Beneficial Effects of Sideritis scardica and Cichorium spinosum against Amyloidogenic Pathway and Tau Misprocessing in Alzheimer's Disease Neuronal Cell Culture Models.”, J Alzheimers Dis, vol. 64, no. 3, pp. 787-800, 2018.
S. Wang, He, B., Hang, W., Wu, N. H., Xia, L., Wang, X., Zhang, Q., Zhou, X., Feng, Z., Chen, Q., and Chen, J., “Berberine Alleviates Tau Hyperphosphorylation and Axonopathy-Associated with Diabetic Encephalopathy via Restoring PI3K/Akt/GSK3β Pathway.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1385-1400, 2018.
S. Wang, He, B., Hang, W., Wu, N. H., Xia, L., Wang, X., Zhang, Q., Zhou, X., Feng, Z., Chen, Q., and Chen, J., “Berberine Alleviates Tau Hyperphosphorylation and Axonopathy-Associated with Diabetic Encephalopathy via Restoring PI3K/Akt/GSK3β Pathway.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1385-1400, 2018.
M. G. Cavuoto, Ong, B., Pike, K. E., Nicholas, C. L., Bei, B., and Kinsella, G. J., “Better Objective Sleep Quality in Older Adults with High Subjective Memory Decline.”, J Alzheimers Dis, vol. 53, no. 3, pp. 943-53, 2016.
B. Cheval, Maltagliati, S., Sieber, S., Cullati, S., Zou, L., Ihle, A., Kramer, A. F., Yu, Q., Sander, D., and Boisgontier, M. P., “Better Subjective Sleep Quality Partly Explains the Association Between Self-Reported Physical Activity and Better Cognitive Function.”, J Alzheimers Dis, vol. 87, no. 2, pp. 919-931, 2022.
B. Cheval, Maltagliati, S., Sieber, S., Cullati, S., Zou, L., Ihle, A., Kramer, A. F., Yu, Q., Sander, D., and Boisgontier, M. P., “Better Subjective Sleep Quality Partly Explains the Association Between Self-Reported Physical Activity and Better Cognitive Function.”, J Alzheimers Dis, vol. 87, no. 2, pp. 919-931, 2022.
H. Lu, Chan, S. S. M., Fung, A. W. T., and Lam, L. C. W., “Beyond a Differential Diagnosis: Cognitive and Morphometric Decoding of Information Processing Speed in Senior Adults with DSM-5 Mild Neurocognitive Disorders.”, J Alzheimers Dis, vol. 58, no. 3, pp. 927-937, 2017.
K. Le Guennec, Tubeuf, H., Hannequin, D., Wallon, D., Quenez, O., Rousseau, S., Richard, A. - C., Deleuze, J. - F., Boland, A., Frebourg, T., Gaildrat, P., Campion, D., Martins, A., and Nicolas, G., “Biallelic Loss of Function of SORL1 in an Early Onset Alzheimer's Disease Patient.”, J Alzheimers Dis, vol. 62, no. 2, pp. 821-831, 2018.
T. Syeda, Sanchez-Tapia, M., Pinedo-Vargas, L., Granados, O., Cuervo-Zanatta, D., Rojas-Santiago, E., Díaz-Cintra, S. A., Torres, N., and Perez-Cruz, C., “Bioactive Food Abates Metabolic and Synaptic Alterations by Modulation of Gut Microbiota in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1657-1682, 2018.
S. Martire, Fuso, A., Mosca, L., Forte, E., Correani, V., Fontana, M., Scarpa, S., Maras, B., and d'Erme, M., “Bioenergetic Impairment in Animal and Cellular Models of Alzheimer's Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions.”, J Alzheimers Dis, vol. 54, no. 1, pp. 307-24, 2016.
A. Russu, Samtani, M. N., Xu, S., Adedokun, O. J., Lu, M., Ito, K., Corrigan, B., Raje, S., Liu, E., H Brashear, R., Styren, S., and Hu, C., “Biomarker Exposure-Response Analysis in Mild-To-Moderate Alzheimer's Disease Trials of Bapineuzumab.”, J Alzheimers Dis, vol. 53, no. 2, pp. 535-46, 2016.
A. Papazacharias, Lozupone, M., Barulli, M. Rosaria, Capozzo, R., Imbimbo, B. P., Veneziani, F., De Blasi, R., Nardini, M., Seripa, D., Panza, F., and Logroscino, G., “Bipolar Disorder and Frontotemporal Dementia: An Intriguing Association.”, J Alzheimers Dis, vol. 55, no. 3, pp. 973-979, 2017.
W. Tarraf, Rodríguez, C. J., Daviglus, M. L., Lamar, M., Schneiderman, N., Gallo, L., Talavera, G. A., Kaplan, R. C., Fornage, M., Conceicao, A., and González, H. M., “Blood Pressure and Hispanic/Latino Cognitive Function: Hispanic Community Health Study/Study of Latinos Results.”, J Alzheimers Dis, vol. 59, no. 1, pp. 31-42, 2017.
N. Voyle, Baker, D., Burnham, S. C., Covin, A., Zhang, Z., Sangurdekar, D. P., Hehir, C. A. Tan, Bazenet, C., Lovestone, S., Kiddle, S., and Dobson, R. J. B., “Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology.”, J Alzheimers Dis, 2015.

Pages